Journal
TRENDS IN MOLECULAR MEDICINE
Volume 19, Issue 3, Pages 187-196Publisher
ELSEVIER SCI LTD
DOI: 10.1016/j.molmed.2012.12.003
Keywords
Parkinson's disease; inflammation; nuclear receptor; Nurr1; PPAR; retinoic acid receptor; glucocorticoid receptor
Ask authors/readers for more resources
Chronic neuroinflammation is associated with the pathophysiology of Parkinson's disease, a movement disorder characterised by deterioration of the nigrostriatal system of the brain. Recent studies have yielded important insights into the regulation of inflammation by nuclear receptors, a superfamily of ligand-activated transcription factors. Certain nuclear receptors are also emerging as regulators of neurodegeneration, including the degeneration of dopaminergic neurons in Parkinson's disease, and the importance of transcriptional control in this process is becoming increasingly apparent. Here, we discuss the role of Nurr1, peroxisome proliferator-activated receptors (PPARs), retinoic acid receptors, and glucocorticoid receptors in neuroinflammatory processes that contribute to dopaminergic neuronal degeneration. We examine current evidence providing insight into the potential of these important players as therapeutic targets for Parkinson's disease.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available